Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals Holding Corp annual/quarterly revenue history and growth rate from 2023 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

• Tonix Pharmaceuticals Holding Corp revenue for the quarter ending March 31, 2026 was 6.9 M, a 183.16% increase year-over-year.
• Tonix Pharmaceuticals Holding Corp revenue for the twelve months ending March 31, 2026 was 14.6 M, a 26.90% increase year-over-year.
• Tonix Pharmaceuticals Holding Corp annual revenue for 2025 was 13.1 M, a 29.85% increase from 2024.
• Tonix Pharmaceuticals Holding Corp annual revenue for 2024 was 10.1 M, a 29.94% increase from 2023.
• Tonix Pharmaceuticals Holding Corp annual revenue for 2023 was 7.8 M.